We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

900926:SSEShanghai Baosight Software Co., Ltd. Class B Analysis

Data as of 2026-06-14 - not real-time

$0.89

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Shanghai Baosight Software is trading well below its 20‑day (0.929), 50‑day (0.977) and 200‑day (1.048) moving averages, indicating a bearish technical backdrop, yet the RSI of 33.8 suggests the stock is approaching oversold territory. The MACD remains in bearish territory with a negative histogram, and volume is on a decreasing trend, reinforcing short‑term downside pressure. Despite this, the company boasts a PE of 14.9 versus an industry average of 36.8, a forward PE of 5.7, and a DCF‑derived fair value of 4.09, implying an upside of over 100% from the current price of 0.893. Cash on hand (4.34 bn) comfortably exceeds debt (1.75 bn), providing a solid balance‑sheet cushion, while the dividend yield of 3.75% is attractive but the payout ratio of 138% raises sustainability concerns. Volatility is elevated at ~25% over the past 30 days, but the beta of 0.25 signals low market‑wide sensitivity, tempering systematic risk. Overall, the stock appears deeply undervalued with modest revenue growth (4.2%) and decent profitability margins, suggesting a potential rebound once technical pressure eases.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI approaching oversold levels
  • Price near identified support at 0.88
  • High dividend yield despite sustainability concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value indicating >100% upside
  • PE ratio far below industry average
  • Strong cash position relative to debt

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic exposure to China's industrial automation demand
  • Sustainable profitability margins and ROE around 10%
  • Undervaluation persisting amid low beta and stable cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin11.21%
P/E Ratio14.9
ROE10.18%
ROA3.48%
Debt/Equity14.16
P/B Ratio1.5
Op. Cash Flow$2.2B
Free Cash Flow$576.3M
Industry P/E36.8

Technical Analysis

TrendBearish
RSI33.8
Support$0.88
Resistance$1.01
MA 20$0.93
MA 50$0.98
MA 200$1.05
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$4.09
Target Price$1.87
Upside/Downside109.57%
GradeUndervalued
TypeValue
Dividend Yield3.75%

Risk Assessment

Beta0.25
Volatility24.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.